The pan-ErbB receptor tyrosine kinase inhibitor canertinib induces ErbB-independent apoptosis in human leukemia (HL-60 and U-937) cells.
about
Lapatinib-binding protein kinases in the African trypanosome: identification of cellular targets for kinase-directed chemical scaffoldsTargeting the EGFR signaling pathway in cancer therapy.Targeting ErbB3: the New RTK(id) on the Prostate Cancer Block.Irreversible pan-ERBB inhibitor canertinib elicits anti-leukaemic effects and induces the regression of FLT3-ITD transformed cells in mice.
P2860
The pan-ErbB receptor tyrosine kinase inhibitor canertinib induces ErbB-independent apoptosis in human leukemia (HL-60 and U-937) cells.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
The pan-ErbB receptor tyrosine ...... kemia (HL-60 and U-937) cells.
@en
The pan-ErbB receptor tyrosine ...... nt apoptosis in human leukemia
@nl
type
label
The pan-ErbB receptor tyrosine ...... kemia (HL-60 and U-937) cells.
@en
The pan-ErbB receptor tyrosine ...... nt apoptosis in human leukemia
@nl
prefLabel
The pan-ErbB receptor tyrosine ...... kemia (HL-60 and U-937) cells.
@en
The pan-ErbB receptor tyrosine ...... nt apoptosis in human leukemia
@nl
P2093
P1476
The pan-ErbB receptor tyrosine ...... kemia (HL-60 and U-937) cells.
@en
P2093
Anna-Lotta Hallbeck
Cecilia Trinks
Emelie A Djerf
Thomas M Walz
P356
10.1016/J.BBRC.2010.01.055
P407
P577
2010-01-22T00:00:00Z